What is The Campbell's Company's earnings per share (EPS)?

The Campbell's Company (CPB) reported diluted earnings per share of $2.01 for fiscal year 2025. This represents a 6.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

The Campbell's Company Financials

CPB

Source SEC Filings (10-K/10-Q) Updated Feb 1, 2026 Currency USD FYE August

This page shows The Campbell's Company (CPB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CPB FY2025 2026-04-22

A steady cash engine is funding dividends while a heavier balance sheet keeps reported earnings recovery muted.

Recently, operating cash flow stayed near $1.1B while interest expense rose to $345M. At the same time, net margin settled at 5.9%, down from 9.2%, showing the core cash engine changed less than reported profit did because financing and other below-gross-profit costs absorbed more of each sales dollar.

The gross margin barely moved, sitting near 30.0% in both recent years. Yet operating margin remained closer to 11.0% than the earlier 14.0% level, which points to pressure from costs below gross profit rather than a major shift in product-level economics.

The company runs with tight day-to-day liquidity: cash was just $168M against $3.13B of current liabilities. That posture is manageable only because operating cash flow remains strong and dividends paid of $459M still sat well below free cash flow of $705M, leaving some room for debt service without a large cash cushion.

Financial Health Signals

Financial Profile 44/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of The Campbell's Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

The Campbell's Company has an operating margin of 11.0%, meaning the company retains $11 of operating profit per $100 of revenue. This results in a moderate score of 48/100, indicating healthy but not exceptional operating efficiency. This is up from 10.4% the prior year.

Growth

The Campbell's Company's revenue grew 6.4% year-over-year to $10.3B, a solid pace of expansion. This earns a growth score of 41/100.

Leverage

The Campbell's Company carries a low D/E ratio of 1.54, meaning only $1.54 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

The Campbell's Company's current ratio of 0.82 is below the typical benchmark, resulting in a score of 11/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

The Campbell's Company has a free cash flow margin of 6.9%, earning a moderate score of 43/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

The Campbell's Company's ROE of 15.2% shows moderate profitability relative to equity, earning a score of 48/100. This is up from 14.8% the prior year.

Altman Z-Score Distress

1.64

The Campbell's Company scores 1.64, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Strong

7/9

The Campbell's Company passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.88x

For every $1 of reported earnings, The Campbell's Company generates $1.88 in operating cash flow ($1.1B OCF vs $602.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.3x

The Campbell's Company earns $3.3 in operating income for every $1 of interest expense ($1.1B vs $345.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$10.3B

YoY+6.4%

5Y CAGR+3.4%

10Y CAGR+2.4%

The Campbell's Company generated $10.3B in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.

EBITDA

$1.6B

YoY+10.4%

5Y CAGR+1.7%

10Y CAGR+1.4%

The Campbell's Company's EBITDA was $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.4% from the prior year.

Net Income

$602.0M

YoY+6.2%

5Y CAGR-18.0%

10Y CAGR-1.0%

The Campbell's Company reported $602.0M in net income in fiscal year 2025. This represents an increase of 6.2% from the prior year.

EPS (Diluted)

$2.01

YoY+6.3%

5Y CAGR-17.8%

10Y CAGR-0.6%

The Campbell's Company earned $2.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 6.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$705.0M

YoY+5.5%

5Y CAGR-8.5%

10Y CAGR-1.6%

The Campbell's Company generated $705.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 5.5% from the prior year.

Cash & Debt

$168.0M

YoY-79.2%

5Y CAGR-25.3%

10Y CAGR-4.4%

The Campbell's Company held $168.0M in cash against $6.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.54

YoY+4.1%

5Y CAGR+1.9%

10Y CAGR+2.1%

The Campbell's Company paid $1.54 per share in dividends in fiscal year 2025. This represents an increase of 4.1% from the prior year.

Shares Outstanding

298M

YoY-0.0%

5Y CAGR-0.3%

10Y CAGR-0.4%

The Campbell's Company had 298M shares outstanding in fiscal year 2025. This represents a decrease of 0.0% from the prior year.

Margins & Returns

Gross Margin

30.4%

YoY-0.4pp

5Y CAGR-4.1pp

10Y CAGR-4.0pp

The Campbell's Company's gross margin was 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin

11.0%

YoY+0.6pp

5Y CAGR-1.8pp

10Y CAGR-2.1pp

The Campbell's Company's operating margin was 11.0% in fiscal year 2025, reflecting core business profitability. This is up 0.6 percentage points from the prior year.

Net Margin

5.9%

YoY-0.0pp

5Y CAGR-12.9pp

10Y CAGR-2.4pp

The Campbell's Company's net profit margin was 5.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.0 percentage points from the prior year.

Return on Equity

15.2%

YoY+0.5pp

5Y CAGR-43.6pp

10Y CAGR-31.9pp

The Campbell's Company's ROE was 15.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.5 percentage points from the prior year.

Capital Allocation

R&D Spending

$100.0M

YoY-2.0%

5Y CAGR+1.5%

10Y CAGR-1.6%

The Campbell's Company invested $100.0M in research and development in fiscal year 2025. This represents a decrease of 2.0% from the prior year.

Share Buybacks

$62.0M

YoY-7.5%

10Y CAGR-12.8%

The Campbell's Company spent $62.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 7.5% from the prior year.

Capital Expenditures

$426.0M

YoY-17.6%

5Y CAGR+7.3%

10Y CAGR+1.1%

The Campbell's Company invested $426.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.6% from the prior year.

CPB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$10.3B+6.4%	$9.6B+3.0%	$9.4B+9.3%	$8.6B+1.0%	$8.5B-2.5%	$8.7B
Cost of Revenue	$7.1B+7.0%	$6.7B+3.5%	$6.4B+8.5%	$5.9B+4.8%	$5.7B-0.5%	$5.7B
Gross Profit	$3.1B+5.0%	$3.0B+1.9%	$2.9B+11.0%	$2.6B-6.5%	$2.8B-6.3%	$3.0B
R&D Expenses	$100.0M-2.0%	$102.0M+10.9%	$92.0M+5.7%	$87.0M+3.6%	$84.0M-9.7%	$93.0M
SG&A Expenses	$674.0M-8.5%	$737.0M+12.7%	$654.0M+6.0%	$617.0M+3.2%	$598.0M-3.9%	$622.0M
Operating Income	$1.1B+12.4%	$1.0B-23.8%	$1.3B+12.8%	$1.2B-24.7%	$1.5B+39.6%	$1.1B
Interest Expense	$345.0M+38.6%	$249.0M+32.4%	$188.0M-0.5%	$189.0M-10.0%	$210.0M-39.1%	$345.0M
Income Tax	$194.0M+2.1%	$190.0M-29.6%	$270.0M+23.9%	$218.0M-33.5%	$328.0M+88.5%	$174.0M
Net Income	$602.0M+6.2%	$567.0M-33.9%	$858.0M+13.3%	$757.0M-24.5%	$1.0B-38.5%	$1.6B
EPS (Diluted)	$2.01+6.3%	$1.89-33.7%	$2.85+13.5%	$2.51-23.7%	$3.29-38.6%	$5.36

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$2.6B-4.2%	$2.7B+10.8%	$2.4B-2.4%	$2.5B-7.8%	$2.7B-3.1%	$2.8B+20.9%	$2.3B-3.2%	$2.4B
Cost of Revenue	$1.8B-2.0%	$1.9B+15.2%	$1.6B-6.4%	$1.7B-6.4%	$1.9B-2.0%	$1.9B+17.7%	$1.6B-1.2%	$1.6B
Gross Profit	$717.0M-9.5%	$792.0M+1.5%	$780.0M+7.1%	$728.0M-11.1%	$819.0M-5.5%	$867.0M+28.4%	$675.0M-7.8%	$732.0M
R&D Expenses	$22.0M-8.3%	$24.0M-14.3%	$28.0M+21.7%	$23.0M-8.0%	$25.0M-3.8%	$26.0M0.0%	$26.0M-3.7%	$27.0M
SG&A Expenses	$160.0M-4.2%	$167.0M-7.2%	$180.0M+11.1%	$162.0M-1.8%	$165.0M-5.7%	$175.0M-3.8%	$182.0M-12.5%	$208.0M
Operating Income	$273.0M-18.8%	$336.0M+12.0%	$300.0M+86.3%	$161.0M-50.8%	$327.0M-10.9%	$367.0M+376.6%	$77.0M-69.0%	$248.0M
Interest Expense	$82.0M+1.2%	$81.0M-11.0%	$91.0M+7.1%	$85.0M-3.4%	$88.0M+1.1%	$87.0M+3.6%	$84.0M+20.0%	$70.0M
Income Tax	$48.0M-22.6%	$62.0M+44.2%	$43.0M+186.7%	$15.0M-79.7%	$74.0M+12.1%	$66.0M+2300.0%	-$3.0M-106.1%	$49.0M
Net Income	$145.0M-25.3%	$194.0M+14.8%	$169.0M+156.1%	$66.0M-61.8%	$173.0M-20.6%	$218.0M+7366.7%	-$3.0M-102.3%	$133.0M
EPS (Diluted)	$0.48-26.2%	$0.65	N/A	$0.22-62.1%	$0.58-19.4%	$0.72	N/A	$0.44

CPB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$15.2B-5.8%	$16.1B+31.5%	$12.3B+0.7%	$12.2B+2.3%	$11.9B-4.2%	$12.4B
Current Assets	$2.6B-18.3%	$3.1B+40.1%	$2.2B-2.8%	$2.3B+22.8%	$1.9B-23.8%	$2.5B
Cash & Equivalents	$168.0M-79.2%	$808.0M+787.9%	$91.0M-30.0%	$130.0M+88.4%	$69.0M-90.4%	$722.0M
Inventory	$1.5B+6.5%	$1.4B+5.4%	$1.3B-1.5%	$1.4B+39.7%	$974.0M+7.0%	$910.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$5.0B-1.3%	$5.1B+27.7%	$4.0B-0.3%	$4.0B-0.2%	$4.0B-0.1%	$4.0B
Total Liabilities	$11.2B-8.5%	$12.3B+44.3%	$8.5B-2.4%	$8.7B+0.5%	$8.7B-10.2%	$9.6B
Current Liabilities	$3.1B-9.7%	$3.5B+50.0%	$2.3B-23.8%	$3.0B+29.7%	$2.3B-19.5%	$2.9B
Long-Term Debt	$6.1B-9.1%	$6.7B+49.0%	$4.5B+12.7%	$4.0B-12.5%	$4.6B-8.6%	$5.0B
Total Equity	$4.0B+3.0%	$3.8B+2.3%	$3.8B+8.3%	$3.5B+7.2%	$3.2B+16.8%	$2.8B
Retained Earnings	$4.8B+2.3%	$4.7B+1.9%	$4.6B+8.3%	$4.2B+8.8%	$3.9B+14.6%	$3.4B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$15.3B+1.1%	$15.2B+1.9%	$14.9B+0.5%	$14.8B-6.8%	$15.9B-1.3%	$16.1B+5.8%	$15.2B-0.1%	$15.2B
Current Assets	$2.7B+6.5%	$2.6B+14.8%	$2.2B+0.3%	$2.2B-30.0%	$3.2B+1.4%	$3.1B+43.2%	$2.2B+2.4%	$2.1B
Cash & Equivalents	$561.0M+233.9%	$168.0M+27.3%	$132.0M-7.7%	$143.0M-82.8%	$829.0M+2.6%	$808.0M+648.1%	$108.0M+0.9%	$107.0M
Inventory	$1.4B-9.6%	$1.5B+5.7%	$1.4B+10.0%	$1.3B+0.5%	$1.3B-8.8%	$1.4B+1.9%	$1.4B+6.6%	$1.3B
Accounts Receivable	N/A	N/A	$541.0M	N/A	N/A	N/A	$587.0M	N/A
Goodwill	$5.0B0.0%	$5.0B0.0%	$5.0B0.0%	$5.0B+0.1%	$5.0B-1.3%	$5.1B-0.4%	$5.1B+0.1%	$5.1B
Total Liabilities	$11.3B+1.1%	$11.2B+2.1%	$11.0B+0.3%	$11.0B-8.7%	$12.0B-2.2%	$12.3B+7.2%	$11.4B+1.0%	$11.3B
Current Liabilities	$2.7B-14.1%	$3.1B+7.7%	$2.9B+2.0%	$2.8B-16.5%	$3.4B-1.5%	$3.5B-3.1%	$3.6B+3.4%	$3.5B
Long-Term Debt	$6.6B+9.0%	$6.1B0.0%	$6.1B0.0%	$6.1B-6.1%	$6.5B-3.1%	$6.7B+16.4%	$5.8B+0.2%	$5.8B
Total Equity	$4.0B+1.2%	$4.0B+1.4%	$3.9B+0.8%	$3.9B-1.0%	$3.9B+1.8%	$3.8B+1.3%	$3.8B-3.0%	$3.9B
Retained Earnings	$4.8B+0.6%	$4.8B+1.6%	$4.7B+0.6%	$4.7B-1.1%	$4.7B+1.2%	$4.7B+2.0%	$4.6B-2.5%	$4.7B

CPB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$1.1B-4.6%	$1.2B+3.7%	$1.1B-3.2%	$1.2B+14.1%	$1.0B-25.9%	$1.4B
Capital Expenditures	$426.0M-17.6%	$517.0M+39.7%	$370.0M+52.9%	$242.0M-12.0%	$275.0M-8.0%	$299.0M
Free Cash Flow	$705.0M+5.5%	$668.0M-13.6%	$773.0M-17.7%	$939.0M+23.6%	$760.0M-30.7%	$1.1B
Investing Cash Flow	-$187.0M+94.0%	-$3.1B-820.0%	-$340.0M-47.8%	-$230.0M-45.6%	-$158.0M-107.0%	$2.3B
Financing Cash Flow	-$919.0M-149.3%	$1.9B+357.7%	-$723.0M+20.5%	-$910.0M+45.5%	-$1.7B+44.1%	-$3.0B
Dividends Paid	$459.0M+3.1%	$445.0M-0.4%	$447.0M-0.9%	$451.0M+2.7%	$439.0M+3.1%	$426.0M
Share Buybacks	$62.0M-7.5%	$67.0M-52.8%	$142.0M-15.0%	$167.0M+363.9%	$36.0M	$0

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$516.0M+130.4%	$224.0M-13.5%	$259.0M+91.9%	$135.0M-73.6%	$512.0M+127.6%	$225.0M-21.9%	$288.0M+35.2%	$213.0M
Capital Expenditures	$100.0M-21.3%	$127.0M-2.3%	$130.0M+52.9%	$85.0M-15.8%	$101.0M-8.2%	$110.0M-22.0%	$141.0M+24.8%	$113.0M
Free Cash Flow	$416.0M+328.9%	$97.0M-24.8%	$129.0M+158.0%	$50.0M-87.8%	$411.0M+257.4%	$115.0M-21.8%	$147.0M+47.0%	$100.0M
Investing Cash Flow	-$97.0M+29.2%	-$137.0M-28.0%	-$107.0M-212.6%	$95.0M+174.2%	-$128.0M-172.3%	-$47.0M+66.7%	-$141.0M+94.8%	-$2.7B
Financing Cash Flow	-$27.0M+47.1%	-$51.0M+68.9%	-$164.0M+82.1%	-$915.0M-152.1%	-$363.0M-169.4%	$523.0M+460.7%	-$145.0M-105.9%	$2.5B
Dividends Paid	$117.0M-2.5%	$120.0M+3.4%	$116.0M0.0%	$116.0M+4.5%	$111.0M-4.3%	$116.0M+4.5%	$111.0M+0.9%	$110.0M
Share Buybacks	$2.0M-91.7%	$24.0M+1100.0%	$2.0M-50.0%	$4.0M+100.0%	$2.0M-96.3%	$54.0M+157.1%	$21.0M+23.5%	$17.0M

CPB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	30.4%-0.4pp	30.8%-0.3pp	31.2%+0.5pp	30.7%-2.5pp	33.2%-1.4pp	34.5%
Operating Margin	11.0%+0.6pp	10.4%-3.6pp	14.0%+0.4pp	13.6%-4.6pp	18.2%+5.5pp	12.7%
Net Margin	5.9%0.0pp	5.9%-3.3pp	9.2%+0.3pp	8.8%-3.0pp	11.8%-6.9pp	18.7%
Return on Equity	15.2%+0.5pp	14.8%-8.1pp	22.9%+1.0pp	21.8%-9.1pp	31.0%-27.8pp	58.8%
Return on Assets	4.0%+0.4pp	3.5%-3.5pp	7.0%+0.8pp	6.2%-2.2pp	8.4%-4.7pp	13.1%
Current Ratio	0.82-0.1	0.91-0.1	0.97+0.2	0.76-0.0	0.80-0.0	0.85
Debt-to-Equity	1.54-0.2	1.75+0.5	1.20+0.0	1.15-0.3	1.41-0.4	1.80
FCF Margin	6.9%-0.1pp	6.9%-1.3pp	8.3%-2.7pp	11.0%+2.0pp	9.0%-3.7pp	12.6%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	28.0%-1.6pp	29.6%-2.7pp	32.3%+2.9pp	29.4%-1.1pp	30.5%-0.8pp	31.3%+1.8pp	29.4%-1.5pp	30.9%
Operating Margin	10.7%-1.9pp	12.6%+0.1pp	12.4%+5.9pp	6.5%-5.7pp	12.2%-1.1pp	13.2%+9.9pp	3.4%-7.1pp	10.5%
Net Margin	5.7%-1.6pp	7.2%+0.2pp	7.0%+4.3pp	2.7%-3.8pp	6.4%-1.4pp	7.9%+8.0pp	-0.1%-5.7pp	5.6%
Return on Equity	3.6%-1.3pp	4.9%+0.6pp	4.3%+2.6pp	1.7%-2.7pp	4.4%-1.2pp	5.7%+5.7pp	-0.1%-3.5pp	3.4%
Return on Assets	0.9%-0.3pp	1.3%+0.2pp	1.1%+0.7pp	0.4%-0.6pp	1.1%-0.3pp	1.4%+1.4pp	-0.0%-0.9pp	0.9%
Current Ratio	1.01+0.2	0.82+0.1	0.77-0.0	0.78-0.2	0.93+0.0	0.91+0.3	0.610.0	0.62
Debt-to-Equity	1.66+0.1	1.54-0.0	1.56-0.0	1.58-0.1	1.66-0.1	1.75+0.2	1.52+0.0	1.47
FCF Margin	16.2%+12.6pp	3.6%-1.7pp	5.3%+3.3pp	2.0%-13.3pp	15.3%+11.2pp	4.2%-2.3pp	6.4%+2.2pp	4.2%

Note: The current ratio is below 1.0 (0.82), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Pilgrims Pride PPC

$6.7B

J M Smucker SJM

$11.1B

Hormel Foods Corp HRL

$11.2B

Kellanova K

$29.0B

General Mills GIS

$17.9B

Frequently Asked Questions

What is The Campbell's Company's annual revenue?

The Campbell's Company (CPB) reported $10.3B in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is The Campbell's Company's revenue growing?

The Campbell's Company (CPB) revenue grew by 6.4% year-over-year, from $9.6B to $10.3B in fiscal year 2025.

Is The Campbell's Company profitable?

Yes, The Campbell's Company (CPB) reported a net income of $602.0M in fiscal year 2025, with a net profit margin of 5.9%.

What is The Campbell's Company's EBITDA?

The Campbell's Company (CPB) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does The Campbell's Company have?

As of fiscal year 2025, The Campbell's Company (CPB) had $168.0M in cash and equivalents against $6.1B in long-term debt.

What is The Campbell's Company's gross margin?

The Campbell's Company (CPB) had a gross margin of 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is The Campbell's Company's operating margin?

The Campbell's Company (CPB) had an operating margin of 11.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is The Campbell's Company's net profit margin?

The Campbell's Company (CPB) had a net profit margin of 5.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does The Campbell's Company pay dividends?

Yes, The Campbell's Company (CPB) paid $1.54 per share in dividends during fiscal year 2025.

What is The Campbell's Company's return on equity (ROE)?

The Campbell's Company (CPB) has a return on equity of 15.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is The Campbell's Company's free cash flow?

The Campbell's Company (CPB) generated $705.0M in free cash flow during fiscal year 2025. This represents a 5.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is The Campbell's Company's operating cash flow?

The Campbell's Company (CPB) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are The Campbell's Company's total assets?

The Campbell's Company (CPB) had $15.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are The Campbell's Company's capital expenditures?

The Campbell's Company (CPB) invested $426.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does The Campbell's Company spend on research and development?

The Campbell's Company (CPB) invested $100.0M in research and development during fiscal year 2025.

Does The Campbell's Company buy back shares?

Yes, The Campbell's Company (CPB) spent $62.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does The Campbell's Company have outstanding?

The Campbell's Company (CPB) had 298M shares outstanding as of fiscal year 2025.

What is The Campbell's Company's current ratio?

The Campbell's Company (CPB) had a current ratio of 0.82 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is The Campbell's Company's debt-to-equity ratio?

The Campbell's Company (CPB) had a debt-to-equity ratio of 1.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is The Campbell's Company's return on assets (ROA)?

The Campbell's Company (CPB) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is The Campbell's Company's Altman Z-Score?

The Campbell's Company (CPB) has an Altman Z-Score of 1.64, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is The Campbell's Company's Piotroski F-Score?

The Campbell's Company (CPB) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are The Campbell's Company's earnings high quality?

The Campbell's Company (CPB) has an earnings quality ratio of 1.88x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can The Campbell's Company cover its interest payments?

The Campbell's Company (CPB) has an interest coverage ratio of 3.3x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is The Campbell's Company?

The Campbell's Company (CPB) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.